PARAMETRIC PORTFOLIO ASSOCIATES LLC - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 148 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,041,000
+28.8%
334,713
+40.0%
0.00%
Q4 2021$808,000
-6.5%
239,015
+1.0%
0.00%
Q3 2021$864,000
-7.8%
236,757
+10.2%
0.00%
-100.0%
Q2 2021$937,000
-32.1%
214,940
-29.3%
0.00%0.0%
Q1 2021$1,380,000
-55.8%
303,879
-44.1%
0.00%
-50.0%
Q4 2020$3,123,000
-21.7%
544,025
-1.3%
0.00%
-33.3%
Q3 2020$3,991,000
+98.3%
551,258
-4.4%
0.00%
+50.0%
Q2 2020$2,013,000
+686.3%
576,718
+234.1%
0.00%
Q1 2020$256,000
+13.8%
172,640
+50.2%
0.00%
Q4 2019$225,000
-75.8%
114,977
-36.7%
0.00%
-100.0%
Q3 2019$929,000
+334.1%
181,520
+508.4%
0.00%
Q2 2019$214,000
-35.3%
29,838
+19.7%
0.00%
Q1 2019$331,000
+169.1%
24,918
+59.7%
0.00%
Q4 2018$123,000
-92.3%
15,602
-87.3%
0.00%
-100.0%
Q1 2018$1,598,000
+26.7%
122,984
-10.3%
0.00%
+100.0%
Q4 2017$1,261,000
+8.0%
137,083
-5.4%
0.00%0.0%
Q3 2017$1,168,000144,9050.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,653,495$10,367,4148.97%
Versant Venture Management, LLC 543,753$3,409,3307.06%
TCG Crossover Management, LLC 5,905,400$37,026,8586.54%
COMMODORE CAPITAL LP 5,738,500$35,9805.42%
Foresite Capital Management IV, LLC 1,787,094$11,205,0794.79%
Saturn V Capital Management LP 1,611,778$5,718,4324.74%
ACUTA CAPITAL PARTNERS, LLC 1,015,000$6,364,0503.92%
Altium Capital Management LP 1,025,000$6,426,7503.27%
Affinity Asset Advisors, LLC 1,143,531$7,169,9392.81%
GREAT POINT PARTNERS LLC 1,550,000$9,718,5001.90%
View complete list of CYMABAY THERAPEUTICS INC shareholders